...Next steps could include investigating the mechanism by which brain lymphatic vessels contribute to MS. Valeant Pharmaceuticals International Inc....
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel. The price is a 2% discount to Xenon's closing price of...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel. The price is a 2% discount to Xenon's closing price of...
...period was aided by $3.8 billion in M&A-related equity raises by Endo International plc and Valeant Pharmaceuticals International Inc.... ...Ltd. (HKSE:1833), Shanghai, China Shenogen Pharma Group Ltd. Beijing, China State Drug Administration, Beijing, China Valeant Pharmaceuticals International Inc....
...acid (ETC-1002) / ezetimibe ASCVD Top-line Ph III data August EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) / Valeant Pharmaceuticals International Inc.... ...NASDAQ:URGN) MitoGel (UGN-101) Low-grade upper tract urothelial carcinoma (UTUC) Top-line Ph III OLYMPUS data 2H18 Valeant Pharmaceuticals International Inc....
...The Ortho Dermatologics unit of Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said it received a complete response letter from... ...Duobrii is a topical formulation of halobetasol propionate, a corticosteroid, and tazarotene, a retinoid prodrug. Valeant Pharmaceuticals International Inc....
...Next steps could include investigating the mechanism by which brain lymphatic vessels contribute to MS. Valeant Pharmaceuticals International Inc....
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel. The price is a 2% discount to Xenon's closing price of...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel. The price is a 2% discount to Xenon's closing price of...
...period was aided by $3.8 billion in M&A-related equity raises by Endo International plc and Valeant Pharmaceuticals International Inc.... ...Ltd. (HKSE:1833), Shanghai, China Shenogen Pharma Group Ltd. Beijing, China State Drug Administration, Beijing, China Valeant Pharmaceuticals International Inc....
...acid (ETC-1002) / ezetimibe ASCVD Top-line Ph III data August EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) / Valeant Pharmaceuticals International Inc.... ...NASDAQ:URGN) MitoGel (UGN-101) Low-grade upper tract urothelial carcinoma (UTUC) Top-line Ph III OLYMPUS data 2H18 Valeant Pharmaceuticals International Inc....
...The Ortho Dermatologics unit of Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) said it received a complete response letter from... ...Duobrii is a topical formulation of halobetasol propionate, a corticosteroid, and tazarotene, a retinoid prodrug. Valeant Pharmaceuticals International Inc....